Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AVA
|
Jason R Thackston
Senior Vice President |
SELL
Open market or private sale
|
Direct | 1,750 Reduced 5.92% |
$80,150
$45.8 p/Share
|
Mar 08
2022 |
|
BXMT
|
Katharine A Keenan
CEO & President |
SELL
Open market or private sale
|
Direct | 1,173 Reduced 0.88% |
$36,727
$31.31 p/Share
|
Mar 08
2022 |
|
WAL
|
Dale Gibbons
Vice Chairman and CFO |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.77% |
$155,540
$77.77 p/Share
|
Mar 08
2022 |
|
WAL
|
Robert Gary Sarver
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 5.7% |
$1,928,000
$77.12 p/Share
|
Mar 08
2022 |
|
CZR
|
Thomas Reeg
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 50.0% |
$713,800
$71.38 p/Share
|
Mar 08
2022 |
|
AKAM
|
Robert Blumofe
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 22.2% |
$873,200
$109.15 p/Share
|
Mar 08
2022 |
|
MOH
|
Steven J Orlando
Director |
SELL
Open market or private sale
|
Indirect | 591 Reduced 2.81% |
$183,801
$311.0 p/Share
|
Mar 08
2022 |
|
EW
|
Larry L Wood
Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct | 7,242 Reduced 3.54% |
$770,404
$106.38 p/Share
|
Mar 08
2022 |
|
EW
|
Larry L Wood
Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct | 7,242 Added 3.42% |
$266,144
$36.75 p/Share
|
Mar 08
2022 |
|
EW
|
Huimin Wang
CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct | 3,675 Reduced 3.61% |
$395,430
$107.6 p/Share
|
Mar 08
2022 |
|
EW
|
Huimin Wang
CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct | 3,675 Added 3.49% |
$129,360
$35.2 p/Share
|
Mar 08
2022 |
|
SMM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,899 Added 0.14% |
$38,702
$7.9 p/Share
|
Mar 08
2022 |
|
KW
|
Fairfax Financial Holdings LTD
Director |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 50.0% |
-
|
Mar 08
2022 |
|
LIN
|
Sanjiv Lamba
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 3,750 Added 10.02% |
$1,007,325
$268.62 p/Share
|
Mar 08
2022 |
|
MLSS
|
Leonard Osser
Director |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 0.17% |
$10,125
$1.35 p/Share
|
Mar 08
2022 |
|
ISTR
|
John J D'Angelo
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 100 Added 0.06% |
$1,981
$19.81 p/Share
|
Mar 08
2022 |
|
HNGR
|
James H Campbell
SVP, Chief Clinical Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 7.52% |
$78,080
$19.52 p/Share
|
Mar 08
2022 |
|
SWBI
|
Deana L Mc Pherson |
BUY
Open market or private purchase
|
Direct | 335 Added 0.56% |
$4,991
$14.9 p/Share
|
Mar 08
2022 |
|
CWST
|
Edmond Coletta
PRESIDENT |
SELL
Open market or private sale
|
Direct | 8,343 Reduced 5.03% |
$709,739
$85.07 p/Share
|
Mar 08
2022 |
|
CNNE
|
Barry B Moullet
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 9.16% |
$23,650
$23.65 p/Share
|
Mar 08
2022 |
|
CEN
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,466 Added 2.39% |
$359,383
$17.56 p/Share
|
Mar 08
2022 |
|
MNTX
|
David J Langevin
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 1,142 Reduced 0.12% |
$8,930
$7.82 p/Share
|
Mar 08
2022 |
|
MNTX
|
Steve Filipov
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,433 Reduced 1.06% |
$11,206
$7.82 p/Share
|
Mar 08
2022 |
|
ESCA
|
Stephen Wawrin
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 1,368 Added 3.67% |
-
|
Mar 08
2022 |
|
ESCA
|
Patrick J Griffin
VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 568 Added 0.11% |
-
|
Mar 08
2022 |
|
ICUI
|
Brian Michael Bonnell
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,209 Added 24.96% |
-
|
Mar 08
2022 |
|
ICUI
|
Brian Michael Bonnell
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,163 Reduced 17.52% |
-
|
Mar 08
2022 |
|
ICUI
|
Vivek Jain
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,524 Added 13.04% |
-
|
Mar 08
2022 |
|
ICUI
|
Vivek Jain
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,328 Reduced 7.89% |
-
|
Mar 08
2022 |
|
ICUI
|
Kevin J Mc Grody
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 442 Reduced 9.94% |
-
|
Mar 08
2022 |
|
ICUI
|
Kevin J Mc Grody
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 841 Added 14.79% |
-
|
Mar 08
2022 |
|
ICUI
|
Virginia Ruth Sanzone
VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 2,272 Added 29.94% |
-
|
Mar 08
2022 |
|
ICUI
|
Virginia Ruth Sanzone
VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,196 Reduced 22.49% |
-
|
Mar 08
2022 |
|
ICUI
|
Daniel Woolson
VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct | 2,020 Added 14.64% |
-
|
Mar 08
2022 |
|
ICUI
|
Daniel Woolson
VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct | 894 Reduced 7.59% |
-
|
Mar 08
2022 |
|
ICUI
|
Christian B. Voigtlander
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,209 Added 13.08% |
-
|
Mar 08
2022 |
|
ICUI
|
Christian B. Voigtlander
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,163 Reduced 7.92% |
-
|
Mar 08
2022 |
|
MXC
|
Thomas H Decker
Director |
SELL
Open market or private sale
|
Direct | 102 Reduced 1.2% |
$3,825
$37.5 p/Share
|
Mar 08
2022 |
|
FUSN
|
John Valliant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 3,004 Reduced 0.76% |
$20,788
$6.92 p/Share
|
Mar 08
2022 |
|
ACHR
|
Marc E. Lore
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 84,020 Added 0.3% |
$265,503
$3.16 p/Share
|
Mar 08
2022 |
|
COMM
|
Claudius E. Iv Watts |
BUY
Open market or private purchase
|
Direct | 4,000 Added 0.8% |
$29,720
$7.43 p/Share
|
Mar 08
2022 |
|
XENE
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct | 14,551 Reduced 7.36% |
$377,744
$25.96 p/Share
|
Mar 08
2022 |
|
AMRC
|
Mark Chiplock
EVP, CFO & CAO |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 100.0% |
$219,000
$73.0 p/Share
|
Mar 08
2022 |
|
AMRC
|
Mark Chiplock
EVP, CFO & CAO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 50.0% |
$30,150
$10.05 p/Share
|
Mar 08
2022 |
|
AMRC
|
Spencer Doran Hole
EVP and CFO |
SELL
Open market or private sale
|
Direct | 16,000 Reduced 100.0% |
$1,211,520
$75.72 p/Share
|
Mar 08
2022 |
|
AMRC
|
Spencer Doran Hole
EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,000 Added 50.0% |
$213,920
$13.37 p/Share
|
Mar 08
2022 |
|
SFM
|
Brandon F. Lombardi
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 18,673 Reduced 29.68% |
$614,528
$32.91 p/Share
|
Mar 08
2022 |
|
H
|
Mark R Vondrasek
Officer |
SELL
Open market or private sale
|
Direct | 3,252 Reduced 79.98% |
$282,534
$86.88 p/Share
|
Mar 08
2022 |
|
AKAM
|
Edward J Mc Gowan
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,052 Reduced 9.68% |
$228,326
$111.27 p/Share
|
Mar 08
2022 |
|
HES
|
John B Hess
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 77,035 Reduced 0.49% |
$7,768,209
$100.84 p/Share
|
Mar 08
2022 |